Testing effectiveness (Phase 2)Looking for participantsNCT07523737
What this trial is testing
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 43